Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (101-110 of 248) with videos related to

Pageof 25
Sort By:
Journal of Affective Disorders|October 7, 2018
Cortical biometals: Changed levels in suicide and with mood disordersBrian Dean, Linh Q Lam, Elizabeth Scarr, et al.
Journal of Nuclear Medicine Technology|August 31, 2011
Survey of the performance of commercial dose calibrators for measurement of ¹²³I activityArnold F Jacobson, Robert Centofanti, Olakiitan I Babalola, et al.
Neuroscience Letters|April 22, 2005
5-HT2A and muscarinic receptors in schizophrenia: a postmortem studyIzuru Matsumoto, Yuki Inoue, Takeshi Iwazaki, et al.
Biological Psychiatry|April 12, 2005
Differential changes in apolipoprotein E in schizophrenia and bipolar I disorderAlison Digney, Dahlia Keriakous, Elizabeth Scarr, et al.
Genome Research|March 4, 2010
Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophreniaAli Torkamani, Brian Dean, Nicholas J Schork, et al.
Synapse (New York, N.Y.)|February 24, 2007
Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brainPhilip Seeman, Françoise Ko, Elaine Jack, et al.
The International Journal of Neuropsychopharmacology|October 18, 2015
Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and AntidepressantsAndrew Stuart Gibbons, Won Je Jeon, Elizabeth Scarr, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 4, 2018
mRNA expression of the P5 ATPase ATP13A4 is increased in Broca's area from subjects with schizophreniaAndrew S Gibbons, Laura M Bell, Madhara Udawela, et al.
Psychiatry Research|December 22, 2007
Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorderBrian Dean, Alison Digney, Suresh Sundram, et al.
Biomedical Chromatography : BMC|November 23, 2022
Exploring the potential of dried plasma collection cards for liquid chromatography coupled with tandem mass spectrometry quantitation of giredestrant in human plasmaYang Tang, Liuxi Chen, Xiaorong Liang, et al.
Pageof 25

Showing results (101-110 of 248) with videos related to

Sort By:
Pageof 25
Journal of Affective Disorders|October 7, 2018
Cortical biometals: Changed levels in suicide and with mood disordersBrian Dean, Linh Q Lam, Elizabeth Scarr, et al.
Journal of Nuclear Medicine Technology|August 31, 2011
Survey of the performance of commercial dose calibrators for measurement of ¹²³I activityArnold F Jacobson, Robert Centofanti, Olakiitan I Babalola, et al.
Neuroscience Letters|April 22, 2005
5-HT2A and muscarinic receptors in schizophrenia: a postmortem studyIzuru Matsumoto, Yuki Inoue, Takeshi Iwazaki, et al.
Biological Psychiatry|April 12, 2005
Differential changes in apolipoprotein E in schizophrenia and bipolar I disorderAlison Digney, Dahlia Keriakous, Elizabeth Scarr, et al.
Genome Research|March 4, 2010
Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophreniaAli Torkamani, Brian Dean, Nicholas J Schork, et al.
Synapse (New York, N.Y.)|February 24, 2007
Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brainPhilip Seeman, Françoise Ko, Elaine Jack, et al.
The International Journal of Neuropsychopharmacology|October 18, 2015
Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and AntidepressantsAndrew Stuart Gibbons, Won Je Jeon, Elizabeth Scarr, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 4, 2018
mRNA expression of the P5 ATPase ATP13A4 is increased in Broca's area from subjects with schizophreniaAndrew S Gibbons, Laura M Bell, Madhara Udawela, et al.
Psychiatry Research|December 22, 2007
Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorderBrian Dean, Alison Digney, Suresh Sundram, et al.
Biomedical Chromatography : BMC|November 23, 2022
Exploring the potential of dried plasma collection cards for liquid chromatography coupled with tandem mass spectrometry quantitation of giredestrant in human plasmaYang Tang, Liuxi Chen, Xiaorong Liang, et al.
Pageof 25